- abnormal spleen morphology / IMPC
- enlarged spleen / IMPC
- abnormal uterus morphology / IMPC
- small seminal vesicle / IMPC
- microphthalmia / IMPC
- abnormal seminal vesicle morphology / IMPC
- abnormal eye morphology / IMPC
- increased circulating creatinine level / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6NCrl-Parp1em1(IMPC)Ccpcz/Ph
Status | Under development - register interest |
EMMA ID | EM:15075 |
International strain name | C57BL/6NCrl-Parp1em1(IMPC)Ccpcz/Ph |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Parp1em1(IMPC)Ccpcz |
Gene/Transgene symbol | Parp1 |
Information from provider
Provider | Institute of Molecular Genetics |
Provider affiliation | Department of Transgenic Models of Diseases, Institute of Molecular Genetics |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased grip strength / IMPC
- decreased total retina thickness / IMPC
- decreased NK cell number / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- abnormal spleen morphology / IMPC
- abnormal uterus morphology / IMPC
- abnormal eye morphology / IMPC
- increased prepulse inhibition / IMPC
- small seminal vesicle / IMPC
- immune system phenotype / IMPC
- increased circulating creatinine level / IMPC
- increased fasting circulating glucose level / IMPC
- abnormal seminal vesicle morphology / IMPC
- microphthalmia / IMPC
- increased effector memory CD8-positive, alpha-beta T cell number / IMPC
- enlarged spleen / IMPC
- abnormal retina inner nuclear layer morphology / IMPC
MGI phenotypes (gene matching)
- decreased cell proliferation / MGI
- skin hyperplasia / MGI
- decreased body weight / MGI
- increased mortality induced by gamma-irradiation / MGI
- abnormal inflammatory response / MGI
- decreased inflammatory response / MGI
- decreased litter size / MGI
- abnormal macrophage physiology / MGI
- enhanced wound healing / MGI
- no phenotypic analysis / MGI
- abnormal leukocyte migration / MGI
- decreased neuron apoptosis / MGI
- abnormal response/metabolism to endogenous compounds / MGI
- abnormal microglial cell physiology / MGI
- elevated level of mitotic sister chromatid exchange / MGI
- increased mortality induced by ionizing radiation / MGI
- induced chromosome breakage / MGI
- decreased susceptibility to kidney reperfusion injury / MGI
- abnormal cell cycle checkpoint function / MGI
- decreased susceptibility to noise-induced hearing loss / MGI
- decreased susceptibility to injury / MGI
- immune system phenotype / MGI
- increased renal glomerular filtration rate / MGI
- decreased circulating creatinine level / MGI
- increased apoptosis / MGI
- abnormal DNA repair / MGI
- decreased circulating tumor necrosis factor level / MGI
- decreased circulating interleukin-1 beta level / MGI
- decreased susceptibility to endotoxin shock / MGI
- decreased physiological sensitivity to xenobiotic / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- prenatal lethality, incomplete penetrance / MGI
- decreased renal tubule apoptosis / MGI
- decreased susceptibility to dopaminergic neuron neurotoxicity / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).